AstraZeneca Pharma India informs about change in senior management

01 Aug 2023 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed about the change in role of Atul Tandon, Business Unit Head – Oncology. He will be transitioning from the said role with effect from close of business hours on July 31, 2023, as he takes up another responsibility within AstraZeneca group. In the interim, the Oncology Business Unit of the Company will be managed by Ayush Kumar Agarwal, who is currently the Director - Commercial Excellence.

The above information is a of company’s filings submitted to BSE. 

Astrazeneca Pharma I Share Price

5405.50 111.55 (2.11%)
14-May-2024 14:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1544.95
Dr. Reddys Lab 5898.45
Cipla 1371.30
Zydus Lifesciences 983.60
Lupin 1640.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.